詳細(xì)說明: 
                
                	
                    
                        
                            
                                | 品牌 | 其他品牌 | 適用領(lǐng)域 | 科研 | 
|---|
| 產(chǎn)地 | 進(jìn)口 | 加工定制 | 是 | 
|---|
                            
                        
                    
                 
          廣州鴻程生物有限公司一家專注于生命科學(xué)的科技企業(yè),由在國(guó)內(nèi)科研試劑領(lǐng)域有著豐富從業(yè)經(jīng)驗(yàn)的技術(shù)團(tuán)隊(duì)和管理團(tuán)隊(duì)組建而成,專營(yíng)進(jìn)口生物試劑,科學(xué)儀器,實(shí)驗(yàn)消耗品等。公司將不斷把上優(yōu)質(zhì)的產(chǎn)品引入國(guó)內(nèi)市場(chǎng),滿足客戶的需求,公司也將緊跟生命科學(xué)的發(fā)展,為廣大科研工作者探索生命科學(xué)的奧秘奉獻(xiàn)綿薄之力.專門從事以抗*BeckmanA63881的磁珠現(xiàn)貨,moltox11-101.5等現(xiàn)貨,transgenomic706020/706025現(xiàn)貨
  NA12878 Coriell InstituteDNA和細(xì)胞廣州鴻程代理
  Coriell Institute作為已被國(guó)際認(rèn)可的quanwei機(jī)構(gòu),致力于為個(gè)性化醫(yī)療和干細(xì)胞生物學(xué)快速發(fā)展做出貢獻(xiàn)。其中,Biobank的人類基因組DNA標(biāo)準(zhǔn)品,已廣泛應(yīng)用被國(guó)內(nèi)各大zhiming基因公司及科研單位所信賴。其中,NA12878在國(guó)內(nèi)也已成為基因組測(cè)序行業(yè)的標(biāo)準(zhǔn)。
  以NA12878為例,展示如下:
  NA12878DNAfromLCL
  Description:
  CEPH/UTAHPEDIGREE1463INTERNATIONALHAPMAPPROJECT-CEPH(PLATEI)[UTAHRESIDENTSWITHANCESTRYFROMNORTHERNANDWESTERNEUROPE]
  CYTOCHROMEP450,SUBFAMILYIIC,POLYPEPTIDE19;CYP2C19
  INTERNATIONALHAPMAPPROJECT-CEPH[UTAHRESIDENTSWITHANCESTRYFROMNORTHERNANDWESTERNEUROPE]
  NACUSTOMSERVICEPLATE01
  Affected:NoData
  Gender:Female
  Age:NoData
  Repository:NIGMSHumanGeneticCellRepository
  Subcollection:CEPH
  RepositoryLinkageFamilies
  Pharmacogenetics
  PIGIConsentedSample
  Quantity:50µg
  Quantitation:MethodPleaseseeourFAQ
  BiopsySource:Peripheralvein
  CellType:B-Lymphocyte
  TissueType:Blood
  Transformant:Epstein-BarrVirus
  Race:Caucasian
  Ethnicity:UTAH/MORMON
  CountryofOrigin:USA
  FamilyMember:2
  RelationtoProband:mother
  Confirmation:Clinicalsummary/Casehistory
  ISCN:46,XX[23].arr[hg19]9p13.1(38,787,480-40,911,212)x3
  Species:Homosapiens
  CommonName:Human
  Remarks:
  Mother;donorsubjecthasasinglebp(G-to-A)transitionatnucleotide681inexon5oftheCYP2C19gene(CYP2C19*2)whichcreatesanaberrantsplicesite.ThechangealteredthereadingframeofthemRNAstartingwithaminoacid215andproducedaprematurestopcodon20aminoacidsdownstream,resultinginatruncated,nonfunctionalprotein.Becauseoftheaberrantsplicesite,a40-bpdeletionoccurredatthebeginningofexon5(frombp643tobp682),resultingindeletionofaminoacids215to227.Thetruncatedproteinhad234aminoacidsandwouldbecatalyticallyinactivebecauseitlackedtheheme-bindingregion.